02.21.25 -- Discover Partners Focused On Cell & Gene Therapy

Our Lentiviral Vector lot release package includes a range of assays to ensure the quality and safety of the vector, including tests for titer, potency, sterility, bioburden, and other characteristics.

ReciBioPharm navigates the rapidly evolving field of virotherapy to support the development and manufacturing of your gene therapies, viral vector vaccines, and oncolytic viruses (OVs).

Learn how a collaborative approach significantly mitigates risk associated with mRNA product manufacturing and fosters greater agility and speed throughout the development process.

Fast-track your cell and gene therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions.

We integrate product and process development to create practical and speedy solutions. Our patient-centric approach ensures that the right products are developed for unmet patient needs.

Learn the principles of commercialization readiness and guidance to address them in process development as well as the best time to implement automation and minimize commercialization risks.

Collaborating in testing programs, we provide flexible partnership models and sample logistics, managing shipments worldwide through our audited partners.

For cell expansion to occur, we use the world-leading cell line: Pro10™ by AskBio. Viralgen is the only company in the world with a license to manufacture for third parties.

We set ambitious goals to provide capacity and capabilities, investing in, building and ultimately deploying best-in-class viral vector manufacturing platforms with cutting-edge technologies.

Combining disruptive technology platforms with genomic medicine development expertise, Precision NanoSystems accelerates the development of LNP formulations and drug products.

Leverage pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality drug products.

Leveraging experience, knowledge, and expertise from viral vector development and manufacturing, we offer a scalable, reproducible, and efficient development solution to de-risk lentivirus production.